Roche May Grant Tamiflu Licensing Rights For Pandemic Use
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche would consider working with governments and manufacturers to produce Tamiflu for stockpiling – but not commercial use – for a bird flu pandemic.
You may also be interested in...
Roche Agrees To Grant Tamiflu Manufacturing Rights To 15 Companies
Teva and Mylan are among the firms that have agreements with Roche to manufacture generic versions of the flu therapy.
Roche Agrees To Grant Tamiflu Manufacturing Rights To 15 Companies
Teva and Mylan are among the firms that have agreements with Roche to manufacture generic versions of the flu therapy.
Roche To Meet With Generic Firms On Tamiflu Rights After Intervention From Senators
Roche agrees to meet with Teva, Mylan, Ranbaxy and Barr to discuss granting manufacturing rights for Tamiflu in order to meet growing global demand for the avian flu antiviral.